Roy Dennis Bloom

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
One Founders Pavilion
3400 Spruce Street
Philadelphia, Pa 19104-6144
Office: (215) 662-4643
Fax: (215) 615-0349
Education:
BSc (Physiology and Biochemistry)
University of Witwatersrand, 1980.
M.B.B.Ch.
University of Witwatersrand, 1983.
Permanent link
 

Description of Research Expertise

Kidney transplant outcomes, Post-transplant diabetes mellitus, hepatitis C in kidney transplantation

Description of Itmat Expertise

Dr. Bloom engages in clinical outcomes research, particularly pertaining to hepatitis C, transplant associated hyperglycemia and combined liver-kidney transplantation. He also has an active interest in immunosuppressive drug trials, both investigator-initiated and biopharmaceutical-initiated multicenter studies.

Selected Publications

Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Monet, OrlowskiJP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, and Kumar D: Solid Organ Transplantation from Hepatitis B Virus Positive Donors: Consensus Guidelines for Recipient Management. American Journal of Transplantation 15(5): 1162-72, May 2015.

Salomon DR, Langnas AN, Reed AI, Bloom RD, Magee JC and Gaston RS for the AST/ASTS Incentives Workshop Group (IWG): AST/ASTS Workshop on Increasing Organ Donation in the United States: Creating an “arc of change” from removing disincentives to testing incentives. American Journal of Transplantation 15(5): 1173-9, May 2015.

Sawinski, Forde K, Trofe-Clark J, Patel P, Olivera B, Goral S and Bloom RD.: Persistent BK Viremia Does Not Increase Intermediate-Term Graft Loss But is Associated with De Novo Donor Specific Antibodies Journal of the American Society of Nephrology 26(4): 966-75, April 2015.

Stevens DR, Sawinski D, Blumberg E, Bloom RD, Trofe-Clark J.: Response to: Lower-dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff. Transplant Infectious Diseases April 2015.

Stevens DS, Sawinski D, Blumberg E, Galanakis N, Bloom RD, Trofe-Clark J: Increased Risk of Breakthrough Infection among Cytomegalovirus Donor Positive/Recipient Negative Kidney Transplant Recipients Receiving Lower-dose Valganciclovir Prophylaxis. Transplant Infectious Disease 17(2): 163-73, April 2015.

Potluri V, Nair Harhay M, Wilson FP, Bloom RD, Reese PP: Kidney Transplant Outcomes among Prior Living Organ Donors with End-stage Renal Disease Journal of the American Society of Nephrology 26(5): 1188-94, March 2015.

Reese PP, Bloom RD; Feldman HI; Garg AX; Mussell A; Shults J; Silber JH: Selecting Appropriate Controls for Kidney Donors American Journal of Transplantation 15(1): 287-288, January 2015.

Reese PR, Shults J, Bloom RD, Mussell A, Harhay MN, Abt P, Levine M, Johansen KL, Karlawish JT, Feldman HI: Functional status, time to transplant, and survival benefit of kidney transplantation among wait-listed candidates. American Journal of Kidney Diseases (in press) 2015.

Sawinski D, Forde KA, Eddinger K, Troxel AB, Blumberg E, Tebas P, Abt PL, Bloom RD: Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients. Kidney International (in press) 2015.

Sawinski D, Bloom RD: Novel Hepatitis C Treatment and the Impact on Kidney Transplantation. Transplantation (in press) 2015.

back to top
Last updated: 05/22/2015
The Trustees of the University of Pennsylvania